Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 235-019-5 | CAS number: 12057-24-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute toxicity: inhalation:
LC50 (4h) 0.94 mg/L aerosol
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1986
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with national standard methods with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- GLP compliance:
- no
- Test type:
- traditional method
- Limit test:
- no
- Species:
- rat
- Strain:
- Fischer 344
- Remarks:
- /Lov
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Four groups of 8 male and 8 female laboratory-raised F344/Lov rats, aged 9 to 12 weeks, were used in the two series of lithium exposures. A single control group consisting of the same number of animals was shared between the two lithium exposure series. The animals were housed two per cage in filter-topped polycarbonate plastic cages (48 X 24 X 20 cm high) with hardwood chip bedding. Rooms were maintained at 68- 72°F, with a relative humidit of 20-50% and a 12-hr light: dark cycle with light starting at 6:00 AM Food (Lab Blox, Allied Mills, Chicago, III.) and water from bottles with sipper tubes were provided ad libitum. The animals were randomly assigned into exposure groups by body weight. Any animal appearing in poor health or having an initial body weight beyond two standard deviations of the group mean for each sex was not used in the study.
- Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- whole body
- Remarks:
- Rochester-type chamber, 1m³
- Vehicle:
- clean air
- Remarks:
- and argon
- Mass median aerodynamic diameter (MMAD):
- >= 0.54 - <= 0.68 µm
- Geometric standard deviation (GSD):
- >= 1.36 - <= 1.56
- Remark on MMAD/GSD:
- The aerosol particles showed the typical branched-chain structure of vaporizationcondensation aerosols of metal oxides
- Details on inhalation exposure:
- Mixture of Li2O and LiOH, contained limited (up to 25%) Li2CO3, generated under conditions of low relative humidity (<25%).
Aerosols flowed through the animal exposure chamber at 200 liters/min.
Analytics: The mass concentration of aerosol in the chamber was monitored by drawing filter samples (0.8 µm Acropore filters, Gelman Instrument Co., Ann Arbor, Mich.) every 15 min throughout the exposure. The filters were weighed with an electrobalance (Model 27. Cahn Instruments. Cerntos. Calif.). An optical aerosol monitor (Model P-5A. Environmental Monitoring Systems, Knoxville, Tenn.) provided real-time monitoring of the aerosol concentration in the chamber. - Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- 4 h
- Concentrations:
- 500, 750, 1000 and 1500 mg/m³
- No. of animals per sex per dose:
- 8
- Control animals:
- yes
- Details on study design:
- - Body weights:
Body weights were measured on Days 0 (preexposure). 1, 5, 8, 14, 21. and 28. Clinical examinations for signs of toxicity (respiratory difficulty, encrustation of blood or mucus around the eyes, nose, or mouth, righting reflexes, etc.) were performed daily.
- Sacrifice and necropsy:
At 14 days after exposure, a portion of the surviving animals were selected randomly for sacrifice by ip injection of a lethal dose of T-61 euthanasia solution (American Hoechst Co., Sommerville. N.J.). The remaining animals were observed for an additional 14 days and then sacrificed. A complete necropsy was performed on all animals. Lung, liver, kidney, and thymus weights were recorded. The thymus, liver, kidneys, and respiratory tract, from nares to lungs, were removed and fixed in 10% neutral buffered Formalin for histopathology. Tissue sections stained with hematoxylin and eosin were prepared for light microscopy. - Statistics:
- The 14-day LC50 values were calculated for the male and female rats separately and combined using probit analysis (Finney, 1964). Because the exposures were not concurrent, and because animals died at various times after exposure, only qualitative comparisons could be made for body weight and organ weight data.
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- 940 mg/m³ air (analytical)
- Based on:
- test mat.
- 95% CL:
- >= 730 - <= 1 200
- Exp. duration:
- 4 h
- Remarks on result:
- other: 14-day observation period
- Mortality:
- The male rats died earlier than the female rats exposed concurrently.
- Clinical signs:
- bodyweight loss
- Remarks:
- excessive salivation and nasal mucus secretion. Coughing and choking, respiratory difficulty, including audible mouth breathing, encrustation of blood and mucus around the eyes and nose, slowing of the righting reflex, and general lethargy.
- Body weight:
- Rapid and persistent weight loss was characteristic of animals in the higher exposure concentration groups.
Animals exposed to only 500 mg/m³ exhibited transient and reversible weight losses. - Gross pathology:
- Alterations were seen in the larynges, turbinates, and lungs of exposed animals. There was a clear dose-response pattern for both males and females in all exposure groups. Laryngeal lesions were the most consistent alterations with all of the lithium aerosols tested. The principal change was necrotic laryngitis. The lesion was segmental, affecting primarly the epiglottis and anterior portions of the larynx with the more distal portions often entirely spared. In affected regions there was mucosal erosion and/or ulceration, submucosal inflammation with extension into laryngeal musculature, and occasional thrombosis of submucosal vessels. There was bacterial colonization of ulcerated surfaces and occasional laryngeal foreign bodies (hair fragments) were present. Mucosal surfaces immediately adjacent to necrotic zones frequently exhibited squamous metaplasia. The majority of animals with laryngeal pathology also had turbinate lesions. Occasional animals had turbinate lesions with no evidence of laryngeal involvement.
Turbinate lesions consisted of focal to patchy erosive to ulcerative rhinitis. The nasal cavity often contained an exudate formed of aggregates of neutrophils enmeshed in mucus. Areas of squamous metaplasia were found within the nasal mucosa. Bacterial colonization and occasional nasal foreign bodies (hair fragments and keratinous debris) were observed. Pulmonary lesions were of varying severity and were present only in animals with laryngeal and/or turbinate involvement. The mildest lesions were rare and consisted of acute multifocal terminal bronchiolitis and associated alveolitis. More severe lesions consisted of patchy diffuse necrotizing pneumonia, often associated with inhaled foreign bodies (hair fragments and keratinous debris) and bacterial colonies. Thymic lesions were also present. The principal change was depletion of cortical lymphocytes with resultant organ atrophy. Multifocal hemorrhage was a common accompaniment. - Other findings:
- Several animals had swollen, inflammed external genitalia.
No clear dose-response relation could be discerned for absolute organ weight or organ weight-to-body weight ratios in the exposed animals. - Interpretation of results:
- other: Category 3 based on EU GHS criteria
- Remarks:
- toxicity based on corrosion
- Conclusions:
- The 14-day LC50 values (with 95% confidence limits) determined after 4-hr exposures were 940 (730-1200) mg/m³ (0.94 mg/L) for the lithium oxide and hydroxide mixture and 960 (830-1200) mg/m³ for the lithium hydroxide aerosols.
- Executive summary:
Male and female F344/Lov rats were exposed to aerosols of Lithium combustion aerosols (Case 3: predominantly lithium monoxide with some lithium hydroxide and about 12% lithium carbonate). The 14-day LC50 values (with 95% confidence limits) determined after 4-hr exposures were 940 (730-1200) mg/m³ (0.94 mg/L) for the lithium oxide and hydroxide mixture and 960 (830-1200) mg/m³ for the lithium hydroxide aerosols. Histopathologic lesions were observed in the nasal turbinates, larynx, and occasionally in the lungs with both aerosols. The most prominent lesions were necrotizing laryngitis and ulcerative rhinitis. Pulmonary lesions represented a secondary extension of the upper respiratory tract lesions rather than a primary manifestation of lithium toxicity. The similarities in the LC50 values and also in the histopathologic lesions observed suggest that any Li2O in the aerosol reacted rapidly with water vapor in the respiratory tract to form LiOH prior to deposition. The type of lesion, primarily necrotizing, supports the suggestion that combustion aerosols of alkali metals exert their toxicity by producing localized areas of high pH upon contact with the tissue, thereby causing protein coagulation.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 0.94 mg/L air
- Physical form:
- inhalation: aerosol
- Quality of whole database:
- good quality
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Justification for classification or non-classification
Due to the corrosive properties of the substance, acute toxicity test are waived. One result of an inhalation study on rats is available revealing the stong basic corrosion properties of the substance. In this study the LC50 (4h) was determined to be 0.94 mg/L aerosol leading to a classification as Category 3 (H331) according to Regulation (EC) No 1272/2008. As the mechanism of toxicity is corrosivity, the test item need to be labelled in addition as EUH071 ‘corrosive to the respiratory tract’.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.